Danaher sees April quarter revenue growth of about 3%, withdraws 2020 guidanceMarket Watch • 04/13/20
New Shutdown Repeal Dates and a Testing Breakthrough Could Be Game-Changers for the MarketThe Motley Fool • 03/30/20
Danaher's Cepheid Receives FDA Emergency Use Authorization For 45-Minute Coronavirus TestBenzinga • 03/22/20